GB226

· Genor Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GB226, covering 2021-03-03 to 2021-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) [Phase 2]